{
  "analysis_timestamp": "2026-01-28T02:35:49.001047",
  "analyses": {
    "benefit_factor": {
      "benefit_sub_factor": "Approved Use (USFDA only)",
      "description": "New indication (<5Y, limited approval)",
      "weight": 60,
      "score": 4,
      "weighted_score": 240,
      "score_type": "benefit",
      "cdsco_approved": false,
      "usfda_approved": true
    },
    "market_experience": {
      "experience_sub_factor": "Established indication (>5Y, approved widely)",
      "description": "Established indication (>5Y, approved widely)",
      "weight": 90,
      "score": 5,
      "weighted_score": 450,
      "score_type": "benefit",
      "years_in_market": 42
    },
    "pubmed_evidence": {
      "evidence_sub_factor": "Low evidence (limited data, uncertain)",
      "description": "Low evidence (limited data, uncertain)",
      "weight": 30,
      "score": 1,
      "weighted_score": 30,
      "score_type": "benefit",
      "rct_count": 12
    },
    "contraindication": {
      "description": "Absolute contraindication/completely restricted",
      "weight": 100,
      "score": 5,
      "weighted_score": 500,
      "score_type": "risk",
      "status": "absolute"
    },
    "therapeutic_duplication": {
      "status": "not_applicable",
      "reason": "Single medication for this condition - no duplication check needed"
    },
    "summary": {
      "drug": "DIVALPROEX SODIUM",
      "diagnosis": "Migraine",
      "total_weighted_score": 1220,
      "total_benefit_score": 720,
      "total_risk_score": 500,
      "brr": 1.44,
      "brr_interpretation": "Acceptable - Benefits slightly outweigh risks",
      "score_breakdown": {
        "pubmed_evidence": {
          "evidence_sub_factor": "Low evidence (limited data, uncertain)",
          "description": "Low evidence (limited data, uncertain)",
          "weight": 30,
          "score": 1,
          "weighted_score": 30,
          "score_type": "benefit",
          "rct_count": 12
        },
        "contraindication_risk": {
          "description": "Absolute contraindication/completely restricted",
          "weight": 100,
          "score": 5,
          "weighted_score": 500,
          "score_type": "risk",
          "status": "absolute"
        }
      },
      "therapeutic_duplication_performed": false,
      "rct_count": 12,
      "has_contraindication": true
    }
  },
  "benefit_risk_ratio": {
    "total_benefit_score": 720,
    "total_risk_score": 500,
    "brr": 1.44,
    "interpretation": "Acceptable - Benefits slightly outweigh risks",
    "benefit_components": 3,
    "risk_components": 1
  }
}